Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W David Henner

Showing results (1-10 of 21) with videos related to

Pageof 3
Sort By:
MLO: Medical Laboratory Observer|August 25, 2012
Nucleic acid testing in oncologyW David Henner, Patricia Biscay
Cancer|February 25, 2003
High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinomaTomasz M Beer, Dianne Lemmon, Bruce A Lowe, et al.
Personalized Medicine|May 20, 2018
Potential clinical utility of gene-expression profiling in identifying tumors of uncertain originMarianne Laouri, Meredith Halks-Miller, W David Henner, et al.
Diagnostic Pathology|March 9, 2010
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression testFederico A Monzon, Fabiola Medeiros, Maureen Lyons-Weiler, et al.
Diagnostic Pathology|August 23, 2012
Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancerAnand Kulkarni, Raji Pillai, Ashley M Ezekiel, et al.
Urology|January 18, 2002
Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxelBrandon M Hayes-Lattin, Peter A Kovach, W David Henner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind Javle, Gilbert N Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimensRaji Pillai, Rebecca Deeter, C Ted Rigl, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost-effectiveness of gene-expression profiling for tumor-site originJohn Hornberger, Irina Degtiar, Hialy Gutierrez, et al.
Pageof 3

Showing results (1-10 of 21) with videos related to

Sort By:
Pageof 3
MLO: Medical Laboratory Observer|August 25, 2012
Nucleic acid testing in oncologyW David Henner, Patricia Biscay
Cancer|February 25, 2003
High-dose weekly oral calcitriol in patients with a rising PSA after prostatectomy or radiation for prostate carcinomaTomasz M Beer, Dianne Lemmon, Bruce A Lowe, et al.
Personalized Medicine|May 20, 2018
Potential clinical utility of gene-expression profiling in identifying tumors of uncertain originMarianne Laouri, Meredith Halks-Miller, W David Henner, et al.
Diagnostic Pathology|March 9, 2010
Identification of tissue of origin in carcinoma of unknown primary with a microarray-based gene expression testFederico A Monzon, Fabiola Medeiros, Maureen Lyons-Weiler, et al.
Diagnostic Pathology|August 23, 2012
Comparison of histopathology to gene expression profiling for the diagnosis of metastatic cancerAnand Kulkarni, Raji Pillai, Ashley M Ezekiel, et al.
Urology|January 18, 2002
Successful treatment of metastatic hormone-refractory prostate cancer with malignant pericardial tamponade using docetaxelBrandon M Hayes-Lattin, Peter A Kovach, W David Henner, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 10, 2005
Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancerTomasz M Beer, Milind Javle, Gilbert N Lam, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|December 31, 2002
Weekly high-dose calcitriol and docetaxel in metastatic androgen-independent prostate cancerTomasz M Beer, Kristine M Eilers, Mark Garzotto, et al.
The Journal of Molecular Diagnostics : JMD|January 14, 2011
Validation and reproducibility of a microarray-based gene expression test for tumor identification in formalin-fixed, paraffin-embedded specimensRaji Pillai, Rebecca Deeter, C Ted Rigl, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|January 23, 2013
Cost-effectiveness of gene-expression profiling for tumor-site originJohn Hornberger, Irina Degtiar, Hialy Gutierrez, et al.
Pageof 3